Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
40%
Ph not_applicable
2
40%
Ph phase_3
1
20%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Active, not recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (40.0%)
Phase 31 (20.0%)
N/A2 (40.0%)

Trials by Status

completed240%
active_not_recruiting240%
withdrawn120%

Recent Activity

2 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.

NCT06920758
active_not_recruitingphase_1

Tocotrienols for Obesity of Postmenopausal Women

NCT03705845
withdrawnphase_1

Tocotrienols for Skeletal Muscle Health

NCT03708354
completednot_applicable

THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease

NCT02719665
completedphase_3

The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia

NCT02407548

Clinical Trials (5)

Showing 5 of 5 trials
NCT06920758Not Applicable

A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.

Active Not Recruiting
NCT03705845Phase 1

Tocotrienols for Obesity of Postmenopausal Women

Active Not Recruiting
NCT03708354Phase 1

Tocotrienols for Skeletal Muscle Health

Withdrawn
NCT02719665Not Applicable

THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease

Completed
NCT02407548Phase 3

The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5